NTRR Launching High-Quality Vapable Product Line for Growing Canadian Market

LAS VEGAS, NV / ACCESSWIRE / September 28, 2016 / Neutra Corp. (OTCQB: NTRR) plans to ship its inaugural order of premium, disposable Diamond Anvil brand vape pens to select Canadian distributors shortly and expects them to hit the market within the next few weeks. The order is the first for Neutra since it acquired Diamond Anvil.

“This is just the initial step in our overall plan to expand our cannabis-related product line,” said NTRR CEO Chris Brown. “We expect this order to help us to strengthen our existing distributor relationships. We also continue to evaluate new technology for a permanent everyday use product. These could include disposable vitamin, oil and energy pens down the line.”

The global market for vape pens, e-cigarettes and related accessories is expected to grow to $47 billion by
2025, some analysts contend. The medicinal cannabis market, meanwhile, could grow to $21.8 billion by 2020, or even to $44 billion that year, according to some published reports.

NTRR is hard at work marketing and promoting new, antimicrobial alternatives to harsh chemicals used in cannabis farms. In 2016, NTRR plans to continue to source out solutions for cannabis producers and consumers alike as the regulated cannabis industry continues to swell in the United States, Canada and beyond. For more information on the company’s mission, please visit www.neutracorp.com.

About Neutra Corp.

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how they grow, what they grow, and how they consume cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, NTRR is constantly combing the industry for the latest and greatest to test, prove and bring to market.

By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (NASDAQ: GWPH), Cara Therapeutics Inc. (NASDAQ: CARA) and 22nd Century Group, Inc. (NASDAQ: XXII). For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

SOURCE: Neutra Corp.

ReleaseID: 446092